Suppr超能文献

由于 NIS 突变导致的甲状腺功能减退症和甲状腺肿的遗传学和表型组学。

Genetics and phenomics of hypothyroidism and goiter due to NIS mutations.

机构信息

Department of Internal Medicine II, Klinikum Grosshadern, Ludwig-Maximilians-University Munich, Germany.

出版信息

Mol Cell Endocrinol. 2010 Jun 30;322(1-2):56-63. doi: 10.1016/j.mce.2010.02.007. Epub 2010 Feb 12.

Abstract

Molecular cloning of the NIS gene in 1996 allowed examination of the molecular basis of congenital hypothyroidism due to iodide transport defect (ITD) many years after the first case was described by Federman et al. in 1958. Since 1997, when the first NIS mutation causing ITD was identified and characterized, 12 different NIS molecular defects have been described in 31 ITD patients. Interestingly, marked clinical heterogeneity between patients with the same NIS mutation and in patients with different mutations in the NIS gene without a clear genotype-phenotype correlation has been observed. The study of NIS mutations as the molecular basis of ITD has not only yielded extremely valuable structure/function information on NIS, but has also provided an important tool for preclinical diagnosis and genetic counseling of ITD patients.

摘要

1996 年,NIS 基因的分子克隆使得人们能够在 Federman 等人于 1958 年首次描述碘转运缺陷(ITD)导致的先天性甲状腺功能减退症的病例多年后,研究其分子基础。自 1997 年首次发现并确定导致 ITD 的 NIS 突变以来,已经在 31 例 ITD 患者中描述了 12 种不同的 NIS 分子缺陷。有趣的是,在具有相同 NIS 突变的患者和在 NIS 基因中具有不同突变但无明显基因型-表型相关性的患者之间,观察到明显的临床异质性。对 NIS 突变作为 ITD 的分子基础的研究不仅为 NIS 的结构/功能提供了极其有价值的信息,而且为 ITD 患者的临床前诊断和遗传咨询提供了重要工具。

相似文献

1
Genetics and phenomics of hypothyroidism and goiter due to NIS mutations.
Mol Cell Endocrinol. 2010 Jun 30;322(1-2):56-63. doi: 10.1016/j.mce.2010.02.007. Epub 2010 Feb 12.
3
Genetics and phenomics of hypothyroidism and goiter due to TPO mutations.
Mol Cell Endocrinol. 2010 Jun 30;322(1-2):38-43. doi: 10.1016/j.mce.2010.02.008. Epub 2010 Feb 12.
5
First case of fetal goitrous hypothyroidism due to SLC5A5/NIS mutations.
Eur J Endocrinol. 2020 Nov;183(5):K1-K5. doi: 10.1530/EJE-20-0255.
6
Congenital dyshormonogenic hypothyroidism with goiter caused by a sodium/iodide symporter (SLC5A5) mutation in a family of Shih-Tzu dogs.
Domest Anim Endocrinol. 2018 Oct;65:1-8. doi: 10.1016/j.domaniend.2018.04.005. Epub 2018 Apr 24.
9
Genetics and phenomics of hypothyroidism and goiter due to iodotyrosine deiodinase (DEHAL1) gene mutations.
Mol Cell Endocrinol. 2010 Jun 30;322(1-2):91-8. doi: 10.1016/j.mce.2010.03.010. Epub 2010 Mar 16.
10
Genetics and phenomics of hypothyroidism and goiter due to thyroglobulin mutations.
Mol Cell Endocrinol. 2010 Jun 30;322(1-2):44-55. doi: 10.1016/j.mce.2010.01.009. Epub 2010 Jan 20.

引用本文的文献

1
Transcriptome Profile of Thyroid Glands in Bile Duct Ligation Mouse Model.
Int J Mol Sci. 2022 Jul 26;23(15):8244. doi: 10.3390/ijms23158244.
3
Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment.
Front Endocrinol (Lausanne). 2021 Jun 23;12:674616. doi: 10.3389/fendo.2021.674616. eCollection 2021.
4
Novel Compound Heterozygous Pathogenic Mutations of in a Chinese Patient With Congenital Hypothyroidism.
Front Endocrinol (Lausanne). 2021 Mar 19;12:620117. doi: 10.3389/fendo.2021.620117. eCollection 2021.
6
Mapping of Ion and Substrate Binding Sites in Human Sodium Iodide Symporter (hNIS).
J Chem Inf Model. 2020 Mar 23;60(3):1652-1665. doi: 10.1021/acs.jcim.9b01114. Epub 2020 Mar 12.
7
The Role of the NIS (SLC5A5) Gene in Papillary Thyroid Cancer: A Systematic Review.
Int J Endocrinol. 2018 Nov 14;2018:9128754. doi: 10.1155/2018/9128754. eCollection 2018.
8
A Novel Missense Mutation in the SLC5A5 Gene in a Sudanese Family with Congenital Hypothyroidism.
Thyroid. 2018 Aug;28(8):1068-1070. doi: 10.1089/thy.2018.0137. Epub 2018 Jun 5.
9
Genetic and functional analysis of two missense mutations in congenital hypothyroidism and goiter.
Oncotarget. 2016 Jul 11;9(4):4366-4374. doi: 10.18632/oncotarget.10525. eCollection 2018 Jan 12.
10
Genotype-phenotype correlations of dyshormonogenetic goiter in children and adolescents from South India.
Indian J Endocrinol Metab. 2016 Nov-Dec;20(6):816-824. doi: 10.4103/2230-8210.192923.

本文引用的文献

1
Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene.
Clin Cancer Res. 2009 Oct 1;15(19):6079-86. doi: 10.1158/1078-0432.CCR-09-0851. Epub 2009 Sep 29.
2
Minireview: The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid.
Endocrinology. 2009 Mar;150(3):1084-90. doi: 10.1210/en.2008-1437. Epub 2009 Feb 5.
4
The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer.
Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1272-81. doi: 10.1007/s00259-008-0775-4. Epub 2008 Apr 11.
5
Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
Gene Ther. 2008 Feb;15(3):214-23. doi: 10.1038/sj.gt.3303057. Epub 2007 Nov 8.
6
SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene.
Gene Ther. 2007 Dec;14(24):1731-8. doi: 10.1038/sj.gt.3303043. Epub 2007 Oct 25.
9
Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone.
Breast Cancer Res Treat. 2008 May;109(2):263-72. doi: 10.1007/s10549-007-9646-0. Epub 2007 Jul 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验